Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

about

Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.

P2860

Q54213225-AB14860B-6C3B-43DA-9130-95496551EEBB

P2860

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

Item

http://www.wikidata.org/entity/Q48104415

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@en

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@nl

type

Item

label

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@en

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@nl

prefLabel

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@en

Drug-induced inhibition of pho ...... ance in neoplastic mast cells.

@nl

P1476

Drug-induced inhibition of pho ...... tance in neoplastic mast cells

@en

P2093

A Reiter

http://www.w3.org/2001/XMLSchema#string

D Berger

http://www.w3.org/2001/XMLSchema#string

G Hoermann

http://www.w3.org/2001/XMLSchema#string

H-P Horny

http://www.w3.org/2001/XMLSchema#string

J Schwaab

http://www.w3.org/2001/XMLSchema#string

K Blatt

http://www.w3.org/2001/XMLSchema#string

K Sotlar

http://www.w3.org/2001/XMLSchema#string

M Arock

http://www.w3.org/2001/XMLSchema#string

M Jawhar

http://www.w3.org/2001/XMLSchema#string

M Willmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.

P2888

leu.2017.338

P304

1016-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2017.338

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29249817

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

phosphorylation

P932

6037300

http://www.w3.org/2001/XMLSchema#string

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

about

P2860

P2860

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932